Human Class I Histone Deacetylase Complexes Show Enhanced Catalytic Activity in the Presence of ATP and Co-immunoprecipitate with the ATP-dependent Chaperone Protein Hsp70
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Antibodies to histone deacetylases (HDACs) have been used to immuno-isolate deacetylase complexes from HeLa cell extracts. Complexes shown to contain HDAC1, HDAC3, HDAC6, and HDAC1+2 as their catalytic subunits have been used in an antibody-based assay that detects deacetylation of whole histones at defined lysines. The class II deacetylase HDAC6 was inactive in this assay, but the three class I enzymes deacetylated all histone lysines tested, although with varying efficiency. In comparison to HDAC1, HDAC3 preferentially deacetylated lysines 5 and 12 of H4 and lysine 5 of H2A. H4 tails in purified mononucleosomes were refractory to deacetylation by both HDAC1 and HDAC3, unless ATP was added to the reaction mix. Surprisingly, ATP also consistently enhanced cleavage of free, non-nucleosomal histones, but not small peptides, by both enzyme complexes. We found no evidence that ATP operates by phosphorylation of components of the HDAC complex, but have shown that HDACs 1, 2, and 3 all co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. Another common ATP-dependent chaperone, Hsp90, was absent from all HDAC complexes tested, whereas Hsp60 associated with HDAC1 only. We suggest that Hsp chaperone proteins enhance the deacetylase activity of HDAC complexes by ATP-dependent manipulation of protein substrates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![FIG. 5 Effect of ATP on deacetylation of radiolabeled core histones by HDAC1 and HDAC3 immunocomplexes. Core histones radiolabeled in vivo with [ 3 H]acetate were incubated with HDAC1 and HDAC3 immunocomplexes, as indicated, and acetate release measured by scintillation counting. Immunocomplexes used in each experiment contained the same level of deacetylase activity, releasing 1.60 nmol of acetate in 2 h from a mixture of H3 and H4 peptides in the standard assay. Reactions were performed in the absence ( H18554 ) or presence ( F ) of 0.5 mM ATP over a time course of 0-120 min. Values are averages from three separate experiments, with error bars indicating standard deviation.](https://figures.cochat.ai/paper-figures/368665ea29b0428daa3097160d3777ca/human-class-i-histone-deacetylase-complexes-show-enhanced-catalytic-activity-in-figure-5.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, it has recently been shown that HDAC3 can affect the acetylation of H2B and H4 in vitro (51).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
The Hsp70 and Hsp60 Chaperone Machines
Bukau, B., & Horwich, A. L. (1998) · Cell · doi:10.1016/s0092-8674(00)80928-9 · Cited by 2,815
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression
Heinzel, T., Lavinsky, R. M., Mullen, T.-M., Söderström, M., Laherty, C. D., Torchia, J., Yang, W.-M., Brard, G., Ngo, S. D., Davie, J. R., et al. (1997) · Nature · doi:10.1038/387043a0 · Cited by 1,214
Research works printed but not linked: 1
- 6. Turner, B. M. (2000) BioEssays 22, 836 -845 · DOI · Paper page
Cited by
Histone Deacetylase Inhibitors: Overview and Perspectives
Dokmanovic, M., Clarke, C., & Marks, P. A. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0324 · Cited by 1,164
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
Schübeler, D., MacAlpine, D. M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van Leeuwen, F., Gottschling, D. E., O'Neill, L. P., Turner, B. M., Delrow, J., et al. (2004) · Genes & Development · doi:10.1101/gad.1198204 · Cited by 796
“In vitro studies suggest that HATs and HDACs can vary widely in their histone preference and furthermore in their preference for a certain lysine (Kuo and Allis 1998; Johnson et al. 2002; Robyr et al. 2002).”
BackgroundSelf-citationLauffer, B. E. L., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., Flicke, B., Ritscher, A., Fedorowicz, G., Vallero, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490706 · Cited by 429
“For example, it has recently been shown that HDAC3 can affect the acetylation of H2B and H4 in vitro (51).”
BackgroundBradbury, C. A., Khanim, F. L., Hayden, R., Bunce, C. M., White, D. A., Drayson, M. T., Craddock, C., & Turner, B. M. (2005) · Leukemia · doi:10.1038/sj.leu.2403910 · Cited by 404
Self-citationHdac3 is essential for the maintenance of chromatin structure and genome stability
Bhaskara, S., Knutson, S. K., Jiang, G., Chandrasekharan, M. B., Wilson, A. J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J.-L., Bonine-Summers, A. R., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.022 · Cited by 353
“Hdac3 deacetylates H4K5ac and H4K12ac in vitro (Johnson et al., 2002), and loss of Hdac3 resulted in an accumulation of H4K5ac, H4K12ac, and H4K16ac, as well as H3K9,K14ac, with little effect on the acetylation of other residues (Figure 3) (Knutson et al.”
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
“Recent data also showed that class I HDACs associate with chaperone proteins such as Hsp70 and the formation of such complexes enhances deacetylase activity (Johnson et al., 2002).”
BackgroundRegulation of histone deacetylase activities
Sengupta, N., & Seto, E. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20179 · Cited by 346
“Incidentally, another ATPdependent chaperone protein, HSP70, has been implicated in enhancing the catalytic activity of HDAC1, 2, and 3 [Johnson et al., 2002].”
BackgroundNonhistone protein acetylation as cancer therapy targets
Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S.-W. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.62 · Cited by 300
Epigenetic responses to environmental change and their evolutionary implications
Turner, B. M. (2009) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2009.0125 · Cited by 293
“However, it is interesting that when these deacetylases are assayed against native histone substates (rather than the commonly used synthetic peptides), their activity is enhanced by ATP and chaperone proteins such as the stress response protein HSP70 (Johnson et al. 2002).”
BackgroundSelf-citationInterplay between HDAC3 and WDR5 Is Essential for Hypoxia-Induced Epithelial-Mesenchymal Transition
Wu, M.-Z., Tsai, Y.-P., Yang, M.-H., Huang, C.-H., Chang, S.-Y., Chang, C.-C., Teng, S.-C., & Wu, K.-J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.012 · Cited by 273
“Specific Histone Marks Are Associated with HypoxiaInduced EMT HDAC3 deacetylates histones with a preference for different acetylated histone marks in vitro (Johnson et al., 2002; Karagianni and Wong, 2007).”
BackgroundHistone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00021 · Cited by 261
Histone deacetylase inhibitors: from target to clinical trials
Kelly, W. K., O’Connor, O. A., & Marks, P. A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1695 · Cited by 253
“There is evidence that HDACs may have different lysine substrate specificities [29,33,49].”
BackgroundHDAC3: taking the SMRT-N-CoRrect road to repression
Karagianni, P., & Wong, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210612 · Cited by 222
“The in vitro results suggested that HDAC3 could completely deacetylate H2A, H4K5Ac and H4K12Ac, but only partially deacetylate H3, H2B, H4K8Ac and H4K16Ac (Johnson et al., 2002).”
InfluentialAssembly of the SMRT–histone deacetylase 3 repression complex requires the TCP-1 ring complex
Guenther, M. G., Yu, J., Kao, G. D., Yen, T. J., & Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.1037502 · Cited by 138
“3130 GENES & DEVELOPMENT 16:3130–3135 © 2002 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/02 $5.00; www.genesdev.org vealed one of these proteins to be Hsc70, which has been previously shown to interact with HDAC3 (Johnson et al. 2002).”
BackgroundInfluentialN-CoR-HDAC Corepressor Complexes: Roles in Transcriptional Regulation by Nuclear Hormone Receptors
Jones, P. L., & Shi, Y. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-55747-7_9 · Cited by 146
Activation of Histone Deacetylase 2 by Inducible Heat Shock Protein 70 in Cardiac Hypertrophy
Kee, H. J., Eom, G. H., Joung, H., Shin, S., Kim, J., Cho, Y. K., Choe, N., Sim, B., Jo, D., Jeong, M. H., et al. (2008) · Circulation Research · doi:10.1161/01.res.0000338570.27156.84 · Cited by 134
Protein complexes and proteome organization from yeast to man
Gavin, A., & Superti‐Furga, G. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00007-8 · Cited by 139
Spotswood, H. T., & Turner, B. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16547 · Cited by 122
“Conversely, where levels of gene expression are to be stably maintained over long periods, patterns of histone modification are stabilized by removing (or inhibiting) the HATs and HDACs targeted to that genomic region.”
BackgroundInfluentialSelf-citationMorey, L., Brenner, C., Fazi, F., Villa, R., Gutierrez, A., Buschbeck, M., Nervi, C., Minucci, S., Fuks, F., & Di Croce, L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-08 · Cited by 124
“The interaction with NuRD not only leads to chromatin remodeling and changes in DNA methylation but also causes a recruitment of two additional HDAC enzymes, which display differences in substrate specificity with respect to HDAC3 (18).”
InfluentialGene expression in mature neutrophils: early responses to inflammatory stimuli
Zhang, X., Kluger, Y., Nakayama, Y., Poddar, R., Whitney, C., DeTora, A., Weissman, S. M., & Newburger, P. E. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0903412 · Cited by 124
“Conversely, chaperone proteins not only facilitate proper folding of polypeptides and protect fully translated proteins from aggregation but also stimulate the activity of histone-deacetylase complexes [50], which are essential for remodeling chromatin structure and transcriptional accessibility [51].”
BackgroundHDAC3 and the molecular brake pad hypothesis
McQuown, S. C., & Wood, M. A. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.005 · Cited by 140
Activator-Induced Spread of Poly(ADP-Ribose) Polymerase Promotes Nucleosome Loss at Hsp70
Petesch, S. J., & Lis, J. T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.015 · Cited by 118
“Heat Shock Factor Facilitates Rapid Acetylation of Histone H2A at Lysine 5 upon Heat Shock HDAC3 has multiple in vivo targets of deacetylation (Karagianni and Wong, 2007), but perhaps its best known targets are the N-terminal tails of histones H2A at lysine 5 (H2AK5) and H4 at lysines 5 and 12 (H4K5 and H4K12) (Johnso…”
In vitro nuclear interactome of the HIV-1 Tat protein
Gautier, V. W., Gu, L., O'Donoghue, N., Pennington, S., Sheehy, N., & Hall, W. W. (2009) · Retrovirology · doi:10.1186/1742-4690-6-47 · Cited by 110
Histone deacetylases in cardiovascular and metabolic diseases
Bagchi, R. A., & Weeks, K. L. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.04.003 · Cited by 112
Histone deacetylases: salesmen and customers in the post‐translational modification market
Brandl, A., Heinzel, T., & Krämer, O. H. (2009) · Biology of the Cell · doi:10.1042/bc20080158 · Cited by 107
“Unlike acetylated peptides, deacetylation of purified mononucleosomes by HDAC1 might require its association with the heatshock proteins Hsp60/Hsp70, but not with Hsp90 (Johnson et al., 2002).”
BackgroundRegulation of protein turnover by heat shock proteins
Bozaykut, P., Özer, N. K., & Karademir-Yilmaz, B. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.012 · Cited by 128
Lanzillotta, A., Pignataro, G., Branca, C., Cuomo, O., Sarnico, I., Benarese, M., Annunziato, L., Spano, P., & Pizzi, M. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.018 · Cited by 101
“Though, as H3 is not a target for the HDAC6 (Johnson et al., 2002), resveratrol did not modify per se the H3 acetylation, but produced a synergistic effect when associated with MS-275.”
BackgroundInfluentialGe, Z., Da, Y., Xue, Z., Zhang, K., Zhuang, H., Peng, M., Li, Y., Li, W., Simard, A. R., Hao, J., et al. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.12.006 · Cited by 99
“Our results therefore suggest that vorinostat reduces Th1 and Th17 responses by decreased expression of IL-12, IL-6 and IL-23, consistent with previous reports (Adachi et al., 2003; Bosisio et al., 2008; Johnson et al., 2002).”
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Chüeh, A. C., Tse, J. W. T., Tögel, L., & Mariadason, J. M. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5863 · Cited by 109
“The role of HDAC1 in p53 deacetylation suggested that p53 may be subjected to hyperacetylation after HDACi treatment, which was subsequently demonstrated in several studies (24, 186).”
InfluentialCloutier, P., & Coulombe, B. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.02.010 · Cited by 108
“Acetylation is a reversible modification and the removal of the acetylation mark is catalyzed by Histone DeAcetylases Complexes (HDAC), a number of which were shown to co-immunoprecipitate with Hsp70 [41].”
BackgroundFaried, A., Sohda, M., Nakajima, M., Miyazaki, T., Kato, H., & Kuwano, H. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.013 · Cited by 90
Mahlknecht, U., Will, J., Varin, A., Hoelzer, D., & Herbein, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3979 · Cited by 89
“HDAC3 preferentially deacetylates histone lysines 5 and 12 of H4 and lysine 5 of H2A (9).”
BackgroundGodman, C. A., Joshi, R., Tierney, B. R., Greenspan, E., Rasmussen, T. P., Wang, H.-W., Shin, D.-G., Rosenberg, D. W., & Giardina, C. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.10.6561 · Cited by 87
Lee, H., Sengupta, N., Villagra, A., Rezai-Zadeh, N., & Seto, E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01971-05 · Cited by 86
“Like HDAC1, HDAC2, and HDAC3, HDAC8 coimmunoprecipitated with the ATP-dependent chaperone protein Hsp70 ( 28 ).”
BackgroundBudding Yeast Silencing Complexes and Regulation of Sir2 Activity by Protein-Protein Interactions
Tanny, J. C., Kirkpatrick, D. S., Gerber, S. A., Gygi, S. P., & Moazed, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6931-6946.2004 · Cited by 96
“Further, the deacetylase activities immunoprecipitated with antibodies to various class I deacetylases do not deacetylate nucleosomes (32).”
BackgroundInfluentialStimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism
Vogelauer, M., Krall, A. S., McBrian, M. A., Li, J.-Y., & Kurdistani, S. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.362467 · Cited by 81
Yang, C., Rahimpour, S., Lu, J., Pacak, K., Ikejiri, B., Brady, R. O., & Zhuang, Z. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221046110 · Cited by 77
Histone Deacetylase 3 Binds to and Regulates the Multifunctional Transcription Factor TFII-I
Wen, Y., Cress, W. D., Roy, A. L., & Seto, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206528200 · Cited by 78
Enzymatic transfer of acetate on histones from lysine reservoir sites to lysine activating sites
Mendoza, M. R., Egervári, G., Sidoli, S., Donahue, G., Alexander, D. C., Sen, P., Garcia, B. A., & Berger, S. L. (2022) · Science Advances · doi:10.1126/sciadv.abj5688 · Cited by 67
“3 of 12 abundant enzyme in the nucleus involved in transcription (15, 16) and because it readily deacetylates histones H3 and H4 (17).”
BackgroundHistone deacetylase 3 is required for centromeric H3K4 deacetylation and sister chromatid cohesionPreprint
Éot-Houllier, G., Fulcrand, G., Watanabe, Y., Magnaghi-Jaulin, L., & Jaulin, C. (2008) · Genes & Development · doi:10.1101/gad.484108 · Cited by 81
“It deacetylates all histone lysines tested in in vitro assays, with a preference for acetylated H4K5, H4K12, and H2AK5 (Johnson et al. 2002).”
BackgroundStructure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62
“HDACs are capable of catalyzing the removal of the N-acetyl group from acetylated lysine residues in histones and non-histone proteins [17,18].”
BackgroundBooth, L., Roberts, J. L., Poklepovic, A., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., & Dent, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21660 · Cited by 62
“HDAC6 is a cytosolic HDAC that regulates the activities of HSP90 and HSP70, and inhibition of HDAC6 function reduces the chaperoning functions of these proteins promoting endoplasmic reticulum stress and autophagy [41, 42].”
BackgroundTranscriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53
Chun, A. C. S., & Jin, D.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307185200 · Cited by 60
George, S., Gaddelapati, S. C., & Palli, S. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909554116 · Cited by 58
“Previous studies have shown that HDAC1 affects the acetylation status of all core histones with varying efficiency (35).”
BackgroundFK228 inhibits Hsp90 chaperone function in K562 cells via hyperacetylation of Hsp70
Wang, Y., Wang, S., Zhang, X., Zhao, M., Hou, C., Xu, Y.-J., Du, Z., & Yu, X. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.076 · Cited by 59
Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway
To, K. K. W., Robey, R. W., Zhan, Z., Bangiolo, L., & Bates, S. E. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0270 · Cited by 59
“It was reported that one of the class I HDACs is the deacetylase of Hsp70 and that romidepsin treatment can increase acetylation of Hsp70 (40).”
BackgroundMitochondria‐derived oxidative stress induces a heat shock protein response
Barrett, M. J., Alones, V., Wang, K. X., Phan, L., & Swerdlow, R. H. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20249 · Cited by 51
“Others also note Hsp70 binds histone deacetylase complexes (HDAC) (Johnson et al., 2002), suggesting Hsp70 may influence more broadly nuclear gene expression via its effects on the recently defined histone epigenetic transcriptional control apparatus (Jenuwein and Allis, 2001).”
BackgroundTargeting histone deacetylases for the treatment of disease
Lawless, M. W., Norris, S., O'Byrne, K. J., & Gray, S. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00571.x · Cited by 53
“The class I HDACs (HDACs 1–3) have been shown to associate with the ATP dependent chaperone Hsp70, and this association enhances deacetylase catalytic activity [327].”
BackgroundMorandini, A. C., Santos, C. F., & Yilmaz, Ö. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw082 · Cited by 54
“Regarding possible mechanisms by which ATP could augment the catalytic activity of HDAC complexes, Johnson et al. investigated whether HDAC activity was enhanced by ATP-dependent phosphorylation of one or more components of the complex by endogenous protein kinases (C. Johnson et al. 2002).”
BackgroundInfluentialCoREST Represses the Heat Shock Response Mediated by HSF1
Gómez, A. V., Galleguillos, D., Maass, J. C., Battaglioli, E., Kukuljan, M., & Andrés, M. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.015 · Cited by 49
Epigenetic Treatment of Neurological Disease
Gray, S. G. (2011) · Epigenomics · doi:10.2217/epi.11.67 · Cited by 46
New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR
Stanya, K. J., & Kao, H. (2009) · Cell Division · doi:10.1186/1747-1028-4-7 · Cited by 45
“HDAC3 alone targets acetylated lysines on histone H2A and lysines K5 and K12 of H4 in vitro [25]; another study reported N-CoR/HDAC3 complexes were specific for H3 in vitro [26].”
BackgroundNon-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor
Niu, G., Cai, W., Chen, K., & Chen, X. S. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0123-2 · Cited by 41
“For example, histone deacetylase (HDAC) is capable of regulating gene expression through diverse mechanisms that include modulation of the histone code and acetylation of many non-histone proteins [39, 40].”
You, D., Richardson, J. R., & Aleksunes, L. M. (2020) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089953 · Cited by 41
Boudadi, E., Stower, H., Halsall, J. A., Rutledge, C. E., Leeb, M., Wutz, A., O’Neill, L. P., Nightingale, K. P., & Turner, B. M. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-11 · Cited by 44
“As the specificity of HDACs for particular histone types tends to be low [9,48], it is likely that the absence of VPA-induced acetylation of certain H3 and H4 lysines across Hoxb loci reflects the absence of catalytically-active HATs of the necessary specificity, rather than variations in HDAC levels or types.”
Self-citationHan, K. A., Shin, W. H., Jung, S., Seol, W., Seo, H., Ko, C. J., & Chung, K. C. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw363 · Cited by 39
“Histones H2, H3 and H4 are the typical substrates of HDAC3 (13).”
BackgroundPucciarelli, S., Terza, A. L., Ballarini, P., Barchetta, S., Yu, T. Y., Marziale, F., Passini, V., Methé, B. A., Detrich, H. W., & Miceli, C. (2009) · Marine Genomics · doi:10.1016/j.margen.2009.03.008 · Cited by 35
Histone deacetylases and repression of the gonadotropin genes
Melamed, P. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.10.008 · Cited by 32
Mai, Y., Liu, D., Murdan, S., & Basit, A. W. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.021 · Cited by 33
Targeting Huntington’s disease through histone deacetylases
Gray, S. G. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0025-7 · Cited by 34
“The class I HDACs (HDACs 1–3) have also been shown to associate with the ATP-dependent chaperone Hsp70, and this association enhances deacetylase catalytic activity (Johnson et al. 2002).”
BackgroundNon-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
Kumar, S., Attrish, D., Srivastava, A., Banerjee, J., Tripathi, M., Chandra, P. S., & Dixit, A. B. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1860016 · Cited by 30
HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
Wang, J., Yun, F., Sui, J., Liang, W., Shen, D., & Zhang, Q. (2022) · Biomedicines · doi:10.3390/biomedicines11010088 · Cited by 37
Mani, C., Tripathi, K., Luan, S., Clark, D. W., Andrews, J. F., Vindigni, A., Thomas, G., & Palle, K. (2020) · Oncogene · doi:10.1038/s41388-020-1167-x · Cited by 27
Environmental sensing by chromatin: An epigenetic contribution to evolutionary change
Turner, B. M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.041 · Cited by 31
Self-citationNakagawa, T., Hattori, S., Nobuta, R., Kimura, R., Nakagawa, M., Matsumoto, M., Nagasawa, Y., Funayama, R., Miyakawa, T., Inada, T., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101030 · Cited by 27
Dai, S., Jia, Y., Wu, S., Isenberg, J. S., Ridnour, L. A., Bandle, R., Wink, D. A., Roberts, D. D., & Karger, B. L. (2008) · Journal of Proteome Research · doi:10.1021/pr800376w · Cited by 26
Functional analysis of the Volvox carteri asymmetric division protein GlsA
Pappas, V., & Miller, S. M. (2009) · Mechanisms of Development · doi:10.1016/j.mod.2009.07.007 · Cited by 27
Histone Acetylation and Deacetylation
Fass, D. M., Kemp, M. M., Schroeder, F. A., Wagner, F. F., Wang, Q., & Holson, E. B. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100036 · Cited by 23
Lv, W., Wei, H.-M., Wang, D.-L., Ni, J., & Sun, F.-L. (2012) · Journal of Cell Science · doi:10.1242/jcs.106336 · Cited by 28
“Several substrates were found to be targets of Hdac3, including histones (Bhaskara et al., 2010; Johnson et al., 2002) and non-histone proteins (Yang et al.”
BackgroundStanfield, B. A., Purves, J. T., Palmer, S. M., Sullenger, B. A., Welty‐Wolf, K. E., Haines, K., Agarwal, S., & Kasotakis, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245169 · Cited by 84
Spotswood, H. T., & Turner, B. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216547 · Cited by 52
Self-citationRole of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases
Tordera, R. M., & Cortés-Erice, M. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_59 · Cited by 21
Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells
Patzlaff, J. S., Terrenoire, E., Turner, B. M., Earnshaw, W. C., & Paulson, J. R. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.05.003 · Cited by 19
“In general, HATs show more specificity than HDACs, which tend to show only limited preference for particular lysines or histones [93-96].”
Self-citationExcipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal
Mai, Y., Afonso-Pereira, F., Murdan, S., & Basit, A. W. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.07.009 · Cited by 19
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Lawless, M. W., Norris, S., O'Byrne, K. J., & Gray, S. G. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582441 · Cited by 20
Nitric oxide modifies chromatin to suppress ICAM-1 expression during colonic inflammation
Li, Q., & Sarna, S. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2011 · Cited by 19
Chen, G., Yan, Q., Liu, L., Wen, X., Zeng, H., & Yin, S. (2022) · Cancers · doi:10.3390/cancers14194718 · Cited by 21
Nazri, J. M., Οικονομοπούλου, Κ., de Araujo, E. D., Kraskouskaya, D., Gunning, P. T., & Chandran, V. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2177251 · Cited by 17
Raouf, Y. S., Sedighi, A., Geletu, M., Frere, G. A., Allan, R. G., Nawar, N., de Araujo, E. D., & Gunning, P. T. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01236 · Cited by 17
The Emerging Role of ATP-Dependent Chromatin Remodeling in Memory and Substance Use Disorders
López, A. J., Hecking, J. K., & White, A. O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186816 · Cited by 16
Mu, W., Murcia, N. S., Smith, K. N., Menon, D. U., Yee, D., & Magnuson, T. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac082 · Cited by 16
“RBBP4 coexists with HDAC1 in deacetylase complexes that broadly deacetylatelysines (Johnson et al. 2002).”
Delanote, V., Impe, K. V., Corte, V. D., Bruyneel, E. A., Vetter, G., Boucherie, C., Mareel, M., Vandekerckhove, J. S., Friederich, E., & Gettemans, J. (2005) · Traffic · doi:10.1111/j.1600-0854.2005.00276.x · Cited by 19
“Hsp70 activity in the nucleus is linked with controlling chromatin modifications relating to RNA polymerase II transcriptional activity (65), and hsp70 co-immunoprecipitates with histone deacetylase complexes (66).”
Background5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market
Körner, M., & Tibes, U. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00005-7 · Cited by 13
Gray, S. G., Iglesias, A. H., Teh, B. T., & Dangond, F. (2003) · Gene Expression · doi:10.3727/000000003783992342 · Cited by 14
Synthetic Chromatin Approaches To Probe the Writing and Erasing of Histone Modifications
Fierz, B. (2014) · ChemMedChem · doi:10.1002/cmdc.201300487 · Cited by 12
Bonomi, R. E., Girgenti, M. J., Krystal, J. H., & Cosgrove, K. (2022) · Complex Psychiatry · doi:10.1159/000524079 · Cited by 17
Travers, H., Spotswood, H. T., Moss, P. A. H., & Turner, B. M. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5632 · Cited by 15
Self-citationProteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins
Engel, J. A., Norris, E. L., Gilson, P. R., Przyborski, J. M., Shonhai, A., Blatch, G. L., Skinner‐Adams, T. S., Gorman, J. J., Headlam, M. J., & Andrews, K. T. (2019) · Experimental Parasitology · doi:10.1016/j.exppara.2019.01.008 · Cited by 14
Transcription suppression is mediated by the HDAC1–Sin3 complex in Xenopus nucleoplasmic extract
Quaas, C. E., Lin, B., & Long, D. T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102578 · Cited by 10
“Although the level of H3K18ac and H3K9/14ac initially increased with Romidepsin treatment, the loss of signal over time argues that they were not responsible for the prolonged increase in transcription seen in Figure 2C. Notably, the chromatin reader BRD4 is preferentially recruited to histones by acetylation of H4K5,…”
BackgroundInfluentialPolsinelli, G. A., & Yu, H. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204538 · Cited by 15
The quality control theory of aging
Ladiges, W. (2014) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v4.24835 · Cited by 12
“which are Class 1, have been shown to co-immunoprecipitate with the ATP-dependent chaperone heat shock protein 70 (HSP-70) involved in the ER stress response (12).”
BackgroundFujii, K., Suzuki, N., Ikeda, K., Hamada, T., Yamamoto, T., Kondo, T., & Iwatsuki, K. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2011.11.010 · Cited by 10
“[38] Johnson CA, White DA, Lavender JS, O'Neill LP, Turner BM.”
BackgroundAggarwal, A., Yadav, B., Sharma, N., Kaur, R., & Rishi, V. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105592 · Cited by 13
Noh, S. J., Jeong, W. J., Rho, J. H., Shin, D. M., Ahn, H. B., Park, W. C., Rho, S. H., Soung, Y. H., Kim, T. H., Park, B.-S., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2166 · Cited by 10
Kurnaz, I. A. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20322 · Cited by 10
Targeting DNA damage response: Threshold, chromatin landscape and beyond
Gonfloni, S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.006 · Cited by 7
“Histone deacetylases (HDACs) promote chromatin condensation and are considered promising targets for cancer therapy because their inhibition is preferentially toxic for some cancer cells (Johnson et al., 2002; Minucci & Pelicci, 2006).”
BackgroundHSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors
Fujii, K., Suzuki, N., Jimura, N., Idogawa, M., Kondo, T., Iwatsuki, K., & Kanekura, T. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.01.002 · Cited by 5
“[24] reported that the binding of class I HDACs (HDAC1, 2, and 3) to HSP70, particularly in the presence of ATP,”
BackgroundHerath, K. E., Kodikara, I. K. M., & Pflum, M. K. H. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104807 · Cited by 4
Seto, E. (2006) · Humana Press eBooks · doi:10.1385/1-59745-024-3:61 · Cited by 4
“In a similar study, HDAC3 immunocomplexes completely deacetylated H2A, H4K5, and H4K12, but only partially deacetylated H3, H2B, H4K8, and H4K16 ( 36 ).”
Background
Metadata
- Authors
- Johnson, C. A., White, D. A., Lavender, J. S., O'Neill, L. P., & Turner, B. M.
- Affiliations
- University of Birmingham (GB)
- Corresponding author
- Turner, Bryan M.
- ORCID
- Johnson, Colin A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 277
- Issue
- 11
- Pages
- 9590-9597
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2142317696
- Semantic Scholar
- 3362a8fb7b9f2c90d6959339a6bce9f9f715563e
- Cited by
- 119
- References
- 54
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 1 · 2014: 6 · 2013: 4 · 2012: 8
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6787 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- histone deacetylase, class I HDACs, HDAC1, HDAC3, HDAC2, HDAC6, HSP70, ATP-dependent chaperones, histone deacetylation, histone lysine acetylation, HSP90, HSP60, nucleosome, protein complex formation
- MeSH terms
- Acetylation, Adenosine Triphosphate, Catalysis, Histone Deacetylases, Histones, Humans, Multienzyme Complexes, Nucleosomes, Precipitin Tests, Chaperonin 60, HSP70 Heat-Shock Proteins, HSP90 Heat-Shock Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.